eClinical Solutions

Discover elluminate Assist, an #AI-enabled chatbot designed to connect users with data insights faster.   In an era of accelerated drug development, sponsors need smarter, more intuitive tools to maximize the value of their data. By leveraging conversational AI, elluminate Assist bridges the gap between users and their data, enabling real-time, plain-language interactions to retrieve and analyze critical trial information. Swipe for benefits, key features and sample use cases. 👉 To learn more about the elluminate platform, visit: https://lnkd.in/e-mvhuAd

#ICYMI 🔔 We recently announced new products aimed at reducing cycle times for biopharma including a #GenAI-powered chatbot and clean progress tracking. To enable our clients’ technology-driven transformation, eClinical Solutions is prioritizing embedded #AI capabilities within the elluminate Clinical Data Cloud® and new platform enhancements, including Protocol Deviations, which centralizes protocol deviation management to enhance oversight and regulatory compliance. Further supporting AI use cases, the elluminate platform now includes an ML-driven Audit Trail Review, which surfaces anomalies related to the frequency and timing of data changes and deletions. ⏰ In addition, newly added Data Classification uses advanced ML LLM and NLP techniques to automatically map incoming data to standards, reducing setup times and optimizing data pipelines. For more details on these product updates and our 2024 milestones, including 20 net new clients, investment by GI Partners, collaboration with Snowflake ❄️, and more, visit: https://lnkd.in/epxWNfu9

In honor of #WomensHistoryMonth, eClinical's VP of Clinical Data Management Diane Lacroix shares her perspective on the importance of representation and support for women, especially in #STEM roles. Although women have made strides in closing the gender gap that has persisted for years in STEM, they are still underrepresented in those fields. #womeninscience #womenintech #womeninstem #womeninleadership #representationmatters

eClinical's Vera Pomerantseva discussed the FDA's recent guidance on protocol deviations and its impact on clinical trial management with Andy Studna at Applied Clinical Trials Magazine. In this interview, Vera highlights the importance of quality by design and critical to quality factors in reducing protocol deviations. She also shares her view on the FDA guidance as an official acknowledgment of existing practices and an opportunity for improvement. 🎬 Watch the interview here: https://lnkd.in/eUGQjwf5

The eClinical team is headed to Orlando for PHUSE US Connect 2025! 🌴 Visit us at Booth #18 and don't miss these speaking sessions from our industry experts. 👇 AR01: Risk-Informed Data Strategies to Streamline Trial Complexity 🎤 Tiina Erb, Senior Portfolio Lead 🕒 Monday, March 17, 1:30-2:00 PM DH01: A Guided User Experience for Automated Mapping 🎤 Nathan Johnson, VP, Product Management 🕒 Monday, March 17, 4:00-4:30 PM Poster Session PP04: An Integrated Approach to Protocol Deviation Management 🎤 Jason Konn, Senior Solutions Consultant 🕒 Tuesday, March 18, 5:30- 7:00 PM More details on #PHUSE US Connect here: https://lnkd.in/gypruqHR

While balancing innovation with caution is crucial, there is a unique opportunity to embed #AI across the drug development life cycle, reducing cycle times and delivering therapies to patients faster, says eClinical's Venu Mallarapu. He recently spoke to Pharma's Almanac to weigh in on the current state of AI in biopharma. Read his full perspective here: https://lnkd.in/ejSF2iZr

On #EmployeeAppreciationDay, we're grateful to recognize the talent, hard work and tireless dedication of the eClinical Solutions team. Thank you for your fearless attitude, boundless energy, and strong commitment to exceeding expectations every day to drive innovation in clinical trials. We celebrate you today - thanks for all you do!

Protocol deviations can be extremely costly to clinical trials, both financially and with patient safety. 💲 ⚕️ eClinical's Vera Pomerantseva recently spoke to Clinical Trials Arena's Abigail Beaney to share why the FDA could go further in its draft guidance, including examples to assist sponsors in implementation. Read the full interview: https://lnkd.in/e7yC-7CB

In honor of #WomensHistoryMonth in March, we sat down with our CMO Vidhi Goel to learn more about her experience as a woman in #STEM, career journey, and hope for the future. Check out Vidhi's responses below! eClinical: 💬 What role does collaboration across sectors play in advancing critical research, and how can women take on more influential roles in these partnerships? VG: 📣 Collaboration is key to driving innovation in clinical research, bringing together expertise from pharma, biotech, and technology to improve patient outcomes. Women can take on more influential roles by seeking leadership opportunities, building strong networks, and mentoring others to ensure diverse voices are represented. 💬 What are you most passionate about/what’s your favorite thing about working in STEM? VG: 📣 I love problem-solving and the impact of clinical research, but what keeps me in this industry is the strong network of mentors, friends, and lifelong relationships I’ve built along the way. 💬 What challenges have you encountered as a woman working in STEM? Did you have any female role models or mentors in your career that supported overcoming these challenges? VG: 📣 Like many women in STEM, I’ve faced challenges in being heard and proving my expertise. I’ve been fortunate to have mentors—both male and female—who encouraged me, supported me, and helped me navigate difficult situations. Their guidance has been invaluable. 💬 What advice do you have for the next generation of young women wanting to pursue a career in STEM? VG: 📣 Believe in yourself, seek mentors, and don’t be afraid to take up space. Stay curious, push past imposter syndrome, and support other women along the way.

AI’s rapid evolution is driving a shift in clinical research. ⏩ What does this mean for the future of data management, collaboration, and innovation? AT #ENGAGE2024, key themes emerged around harnessing the potential of AI — especially #GenAI — and the reinvention needed to fully integrate these technologies into clinical trial operations. Our blog explores eight #AI considerations for 2025: https://lnkd.in/eaAuTQ_K